Explore more publications!
Today in Medicine
Got News to Share?

Press Releases

Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026
Feb. 17, 2026

Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026

Indeterminate GlobeNewswire, Inc.
Adial Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb. 17, 2026

Adial Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Indeterminate GlobeNewswire, Inc.
Nasus Pharma to Present Data Highlighting Superior Nasal Deposition and Stability of Intranasal Epinephrine Powder at AAAAI 2026
Feb. 17, 2026

Nasus Pharma to Present Data Highlighting Superior Nasal Deposition and Stability of Intranasal Epinephrine Powder at AAAAI 2026

Indeterminate GlobeNewswire, Inc.
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026
Feb. 17, 2026

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026

Indeterminate GlobeNewswire, Inc.
InfusaLounge Marks New Era in North Texas Healthcare with Expansion into Integrative & Functional Medicine
Feb. 17, 2026

InfusaLounge Marks New Era in North Texas Healthcare with Expansion into Integrative & Functional Medicine

Neutral EIN Presswire
Essential Pharma strengthens rare disease portfolio with acquisition of Ventavis® (iloprost trometamol) for adult primary pulmonary hypertension
Feb. 17, 2026

Essential Pharma strengthens rare disease portfolio with acquisition of Ventavis® (iloprost trometamol) for adult primary pulmonary hypertension

Indeterminate GlobeNewswire, Inc.
Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board
Feb. 17, 2026

Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board

Indeterminate GlobeNewswire, Inc.
INVESTOR DEADLINE: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
Feb. 17, 2026

INVESTOR DEADLINE: Ultragenyx Pharmaceutical Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

Indeterminate GlobeNewswire, Inc.
MedSEO Launches First GEO and SEO Firm Built Exclusively for Healthcare Amid 40M Daily Medical Queries to ChatGPT
Feb. 17, 2026

MedSEO Launches First GEO and SEO Firm Built Exclusively for Healthcare Amid 40M Daily Medical Queries to ChatGPT

Indeterminate GlobeNewswire, Inc.
Nature Medicine Publishes Helus Pharma’s Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder
Feb. 17, 2026

Nature Medicine Publishes Helus Pharma’s Randomized, Placebo-Controlled Phase 2a Trial of SPL026 in Major Depressive Disorder

Indeterminate GlobeNewswire, Inc.
PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm
Feb. 17, 2026

PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Indeterminate GlobeNewswire, Inc.
Portnoy Law Firm Announces Class Action on Behalf of Charming Medical Limited Investors
Feb. 17, 2026

Portnoy Law Firm Announces Class Action on Behalf of Charming Medical Limited Investors

Indeterminate GlobeNewswire, Inc.
Blue Water Spa Earns Best Medical Spa and Best Spa Experience in Raleigh at Midtown Magazine’s 2026 Diamond Awards
Feb. 17, 2026

Blue Water Spa Earns Best Medical Spa and Best Spa Experience in Raleigh at Midtown Magazine’s 2026 Diamond Awards

Neutral EIN Presswire
COSMAX Establishes First European Production Base with Strategic Acquisition of Italy’s Keminova
3 hours ago

COSMAX Establishes First European Production Base with Strategic Acquisition of Italy’s Keminova

Indeterminate GlobeNewswire, Inc.
Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering
Feb. 17, 2026

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering

Indeterminate GlobeNewswire, Inc.
FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference
Feb. 17, 2026

FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference

Indeterminate GlobeNewswire, Inc.
argenx to Present at TD Cowen 46th Annual Healthcare Conference
4 hours ago

argenx to Present at TD Cowen 46th Annual Healthcare Conference

Indeterminate GlobeNewswire, Inc.
Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
Feb. 17, 2026

Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™

Indeterminate GlobeNewswire, Inc.
AMT Medical Appoints Geert van Gansewinkel as CEO to Lead Company into Next Growth Phase Revolutionizing Coronary Artery Bypass Surgery
Feb. 17, 2026

AMT Medical Appoints Geert van Gansewinkel as CEO to Lead Company into Next Growth Phase Revolutionizing Coronary Artery Bypass Surgery

Indeterminate GlobeNewswire, Inc.
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
Feb. 17, 2026

Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions